SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 377 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.81 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $1,754,590 | -24.8% | 11,105 | -38.4% | 0.25% | -16.8% |
| Q1 2024 | $2,333,905 | +123.6% | 18,028 | +66.6% | 0.30% | +46.3% |
| Q4 2023 | $1,043,758 | +259.2% | 10,824 | +351.6% | 0.20% | +141.7% |
| Q3 2023 | $290,564 | +107.8% | 2,397 | +96.3% | 0.08% | +95.3% |
| Q2 2023 | $139,829 | -14.9% | 1,221 | +2.4% | 0.04% | -23.2% |
| Q1 2023 | $164,293 | +42.1% | 1,192 | +33.6% | 0.06% | +21.7% |
| Q4 2022 | $115,585 | +27.0% | 892 | +8.8% | 0.05% | +21.1% |
| Q3 2022 | $91,000 | – | 820 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Evolutionary Tree Capital Management, LLC | 68,937 | $5,138,000 | 3.04% |
| Avoro Capital Advisors LLC | 2,150,000 | $160,240,000 | 2.77% |
| Casdin Capital, LLC | 550,000 | $40,992,000 | 1.22% |
| TOBAM | 371,107 | $27,659,000 | 1.18% |
| Ikarian Capital, LLC | 455,900 | $33,978,000 | 1.14% |
| Eventide Asset Management | 697,156 | $51,959,000 | 0.77% |
| FOX RUN MANAGEMENT, L.L.C. | 4,902 | $365,000 | 0.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 31,500 | $2,348,000 | 0.62% |
| Sivik Global Healthcare LLC | 20,000 | $1,491,000 | 0.54% |
| Rock Springs Capital Management LP | 328,750 | $24,502,000 | 0.54% |